The abstract is read at the publisher; the summary is JClub's.
In a multi-ancestry cohort of 58,559 individuals with Parkinson’s disease, 2.1% carried a causal variant, with frequencies ranging from 0.4% in African to 10.7% in Ashkenazi Jewish ancestry.
- Why it matters: Most Parkinson’s genetic studies have emphasized European ancestry, leaving uncertainty about how causal and clinically relevant risk variants distribute across populations and how this affects diagnosis and trial relevance.
- What they did: Using GP2 release 11 retrospective genome/exome/array data from 99,783 participants across 11 inferred ancestries, the study computed allele frequencies for established Parkinson’s disease causal and risk variants, including copy number variants, in MDS-recommended genes.
- The result: GBA1 and LRRK2 risk variants were found in 11.8% and 8.7% of cases versus controls, with strong ancestry-specific spectra; these findings support more diverse research to improve diagnostic accuracy and equitable access to genetically informed therapies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- 2 cited this week
- Open access